Johnson and Johnson Pharmaceutical Research and Development, LLC (PA)
Welsh and McKean Roads
Spring House
Pennsylvania
19477-0776
United States
Tel: 215-628-5000
Website: http://www.jnj.com/
22 articles about Johnson and Johnson Pharmaceutical Research and Development, LLC (PA)
-
Johnson and Johnson Pharmaceutical Research and Development, LLC (PA): New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
12/2/2009
-
FDA Approves Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)'s (JOBS) INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
8/3/2009
-
Johnson and Johnson Pharmaceutical Research and Development, LLC (PA): New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
5/27/2009
-
Bayer AG and Johnson and Johnson Pharmaceutical Research and Development, LLC (NJ) Release: Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
11/11/2008
-
Tekmira Pharmaceuticals Corporation Announces Presentation of Data Using SNALP RNAi Delivery Technology
10/22/2008
-
Sareum Ltd. Extension of Collaboration with Johnson and Johnson Pharmaceutical R&D (NJ)
3/31/2008
-
Johnson and Johnson Pharmaceutical R&D (NJ) Release: Three Phase III Trials Show Rivaroxaban Outperformed Enoxaparin in Preventing Venous Thromboembolism After Major Orthopedic Surgery
12/10/2007
-
New Drug Application Submitted For Johnson and Johnson Pharmaceutical R&D (NJ) Novel Investigational Antibiotic Ceftobiprole
5/21/2007
-
Johnson and Johnson Pharmaceutical R&D (PA) (Jobs) to Add 120 New Jobs in Pharm Country
4/20/2007
-
Galapagos Genomics NV to Supply Chemical Compound Sets to Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V.
3/8/2007
-
Sareum Ltd. To Collaborate With Johnson & Johnson Pharmaceutical Research & Development, Division Of Janssen Pharmaceutica N.V.
1/22/2007
-
Illumina, Inc. To Conduct Custom Genotyping For Johnson and Johnson Pharmaceutical Research and Development, LLC (CA)
7/13/2006
-
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) And Johnson And Johnson and Johnson Pharmaceutical Research and Development, LLC Initiate Phase III Clinical Trial With VELCADE(R) For Injection In Follicular Non-Hodgkin's Lymphoma
4/18/2006
-
Entelos, Inc. Announces Expanded Collaboration With Johnson and Johnson Pharmaceutical Research and Development, LLC (CA)
3/16/2006
-
PamGene Platform Adopted For Kinase Drug R&D Program: Collaboration With Johnson and Johnson Pharmaceutical R&D (NJ)
3/9/2006
-
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) And Johnson and Johnson Pharmaceutical R&D (NJ) Initiate Randomized Phase II Trial Of VELCADE(R) (Bortezomib) For Injection In Non-Small Cell Lung Cancer
3/6/2006
-
GeneGo, Inc. Expands License With Johnson and Johnson Pharmaceutical R&D (NJ) To Include MetaBase Access
2/20/2006
-
Hurel Corporation And Johnson and Johnson Pharmaceutical R&D Enter Into Joint Scientific Collaboration
7/25/2005
-
United Devices To Build Global Enterprise Grid Infrastructure For Johnson & Johnson Pharmaceutical Research & Development
1/27/2005
-
Johnson & Johnson Pharmaceutical Research & Development Release: Novel Antibiotic Shows Promise In Shortening Treatment Duration Of Tuberculosis
12/9/2004